You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17911 - 17920 of 18922 results
  1. RFA-DA-22-023: Advancing Validated Drug Targets for Substance Use Disorders (R43/R44- Clinical Trial Not Allowed)

    Release Date: 07-29-2021Open Date: 01-18-2022Due Date: 02-18-2022Close Date: 02-19-2022

    Background Substance use disorders (SUDs) affect people from all walks of life and all age groups. These illnesses are common, recurrent, and often serious, but they are treatable, and many people recover. SUDs occur when the recurrent use of drugs causes clinically significant impairment, including health problems, disability, and failure to meet major responsibilities at work, school, or home. ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  2. N131-062: Advancing the State of the Art in Artificial Intelligence for Simulation Training

    Release Date: 11-16-2012Open Date: 12-17-2012Due Date: 01-16-2013Close Date: 01-16-2013

    OBJECTIVE: Develop Artificial Intelligence (AI) software that is generalized across entity-level simulation systems and can be used in training simulation to generate entity behaviors that are both contextually and tactically realistic. DESCRIPTION: The United States Marine Corps (USMC) has been a pioneer in using commercial gaming technology for training. The current small unit training simul ...

    SBIRDepartment of DefenseNavy
  3. RFA-HD-18-102: Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)

    Release Date: 11-22-2017Open Date: 12-22-2017Due Date: 01-22-2018Close Date: 01-22-2018

    The purpose of this initiative is to invite SBIR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women globally ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  4. RFA-HD-18-101: Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41)

    Release Date: 11-22-2017Open Date: 12-22-2017Due Date: 01-22-2018Close Date: 01-22-2018

    Purpose The purpose of this initiative is to invite STTR applications to stimulate new and innovative multipurpose prevention technologies (MPTs) through the development of new combinations of agents and delivery systems to prevent HIV infection and unintended pregnancy among adolescent girls and young women. HIV and unintended pregnancy are two major public health problems affecting young women ...

    STTRPhase IDepartment of Health and Human ServicesNational Institutes of Health
  5. a: Advancing the Science of High Energy Density Laboratory Plasma

    Release Date: 07-29-2011Open Date: 08-02-2011Due Date: 09-17-2011Close Date: 09-17-2011

    The Department has an interest in producing and developing the science of high-energy-density plasmas. Research and development activities are sought to support on-going activities in laser-driven, pulsedpower- driven, and heavy-ion-driven high-energy-density plasma physics. Proposed work should be focused on a specific application, diagnostic or need that would lead to potential commercialization ...

    SBIRPhase IDepartment of Energy
  6. A22-013: Advancing the Science of Additive Manufacturing for a Rapidly Deployable, Energy Efficient System the Modular Assembly Shelter (MASh) Kit

    Release Date: 04-20-2022Open Date: 05-18-2022Due Date: 06-15-2022Close Date: 06-15-2022

    OUSD (R&E) MODERNIZATION PRIORITY: Autonomy, General Warfighting Requirements (GWR) TECHNOLOGY AREA(S): Materials, Human Systems OBJECTIVE: The Modular Assembly Shelter (MASh) Kit (Patent # 10,612,233), developed by the Construction Engineering Research Laboratory (ERDC-CERL), is an innovative system designed to use lightweight materials for expeditionary shelters and capitalize on the adv ...

    SBIRPhase I/Phase IIDepartment of DefenseArmy
  7. 16a: Advancing Technology for Offshore Wind Resource Characterization

    Release Date: 11-30-2015Open Date: 11-30-2015Due Date: 02-09-2016Close Date: 02-09-2016

    16a Department of Energy ...

    SBIRPhase IDepartment of Energy
  8. PAS-18-187 : Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

    Release Date: 11-28-2017Open Date: 03-06-2018 Due Dates: Multiple Close Date: 09-05-2019

    In the United States (US), it is estimated that more than 5 million people suffer from Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD). By 2050 this number is forecast to rise to more than 15 million. Moreover, caring for and treating patients with AD/ADRD is expensive. Current estimated annual costs for AD/ADRD care and treatment total approximately $200 billi ...

    SBIRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  9. PAS-18-188: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)

    Release Date: 11-28-2017Open Date: 03-06-2018 Due Dates: Multiple Close Date: 09-05-2019

    In the United States (US), it is estimated that more than 5 million people suffer from Alzheimer's disease (AD) and Alzheimer's-disease-related dementias (ADRD). By 2050 this number is forecast to rise to more than 15 million. Moreover, caring for and treating patients with AD/ADRD is expensive. Current estimated annual costs for care and treatment of AD/ADRD total approximately $200 bi ...

    STTRPhase I/Phase IIDepartment of Health and Human ServicesNational Institutes of Health
  10. PAS-19-316 : Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional)

    Release Date: 07-18-2019Open Date: 12-05-2019 Due Dates: Multiple Close Date: 09-05-2022

    Recent recommendations and milestones for AD/ADRD research from the National Alzheimer’s Project Act, the 2015 Alzheimer’s Disease Research Summit, the 2018 Alzheimer’s Disease Research Summit, and the 2019 Alzheimer’s Disease and Related Dementias Research Summit present a wide range of research and development proposals which, if pursued, can reduce the human burden and healthcare costs ...

    SBIRPhase I/Phase IIDepartment of Health and Human Services
US Flag An Official Website of the United States Government